Abstract
Introduction: Drug resistant epilepsy, is presented in the 30% or 35% of the cases. The epilepsy surgery is an option to drive in this subgroup, being resective surgeries when the epileptogenic focus is extirped, and palliative surgeries when the target is to dismisse the number of crisis.
Objective: The goal in this reviewing is to present effectiveness and safety outcomes in epilepsy surgery in Bucaramanga.
Materials and methods: Retrospective and descriptive study of series of cases, taken from the patients operated of refractary epilepsy surgery in the Fundación cardiovascular of Colombia, since january 2010 until october 2015; review recordsof patients, to assess the demographic characteristic and the efficacy and safety of the procedures performed, based on Engel classification for freedom of crisis 1 year follow-up and post-surgical complications
Results: In this length of time, were operated 26 patients, 16 men and 10 women, with an average of age 22,5 years; media of age at the beginning of the epilepsy 7 years; with the time of evolution of the epilepsy at the momento of the surgery 22 years for adults, and 5,7 years for childen (less tan 18 years); were performed 16 resective surgeries (13 temporal lobe and 3 extratemporal) and 10 palliative surgeries (9 VNS implantations and 1 callosotomy); we evaluated the postoperative outcomes, just in 21 patients who have more than 12 months of following, we get the next results: temporal lobe resective surgeries (9/10) 90% in Engel I, VNS implantations (7/7) and callosotomy (1/1) 100% in Engel III, and extratemporal resective surgeries (2/3) 66% in Engel I; the media of postoperative hospitalization days were 4,7; and the more frequently complications were the contenied CSF leak and transitory depression and anxiety postoperative.
Discussion: The effectiveness and safety of epilepsy surgery in our series is similar to that shown in the literature.
Conclusion: We can say that in our center, patients who have operated have benefited from this treatment option for drug resistant epilepsy. 5-year follow up of this cohort to validate these results is required.
References
ATEHORTÚA M, SUAREZ J. Clinical characterization and cognitive profile before and after surgery for drug- resistant epilepsy. Acta Neurológica Colombiana. 2011;23:133-142.
BOTERO G, URIBE C. Refractory Epilepsy. Acta Neurólogica Colombiana. 2010;26:34-46.
JOBST B, CASCINO G. Resective Epilepsy Surgery for Drug-Resistant Focal Epilepsy. JAMA. 2015;313(3):285.
DURNFORD A, RODGERS W, KIRKHAM F, MULLEE M, WHITNEY A, PREVETT M ET AL. Very good inter-rater reliability of Engel and ILAE epilepsy surgery outcome classifications in a series of 76 patients. Seizure. 2011;20(10):809-812.
HERRERA E. Cirugía de epilepsia refractaria en niños y adolescentes. Serie de casos. Arch Argent Pediat. 2012;110(4):334-337.
JIMÉNEZ M, SÁNCHEZ J, GIRALDO M, TOBÓN N, GONZÁLEZ J. Manejo quirúrgico y Test de Wada en la epilepsia refractaria del lóbulo temporal. Acta Neurológica Colombiana. 2005;21:269-279.
MEGUINS L, ADRY R, SILVA-JUNIOR S, ARAÚJO FILHO G, MARQUES L. Shorter epilepsy duration is associated with better seizure outcome in temporal lobe epilepsy surgery. Arq Neuro-Psiquiatr. 2015;73(3):212-217.
WIEBE S, BLUME W, GIRVIN J, ELIASZIW M. A Randomized, Controlled Trial of Surgery for Temporal-Lobe Epilepsy. New England Journal of Medicine. 2001;345(5):311-318.
SCHMIDT D, STAVEM K. Long-term seizure outcome of surgery versus no surgery for drug-resistant partial epilepsy: A review of controlled studies. Epilepsia. 2009;50(6):1301-1309.
ULATE-CAMPOS A, CEAN-CABRERA L, PETANAS-ARGEMI J, GARCÍA-FRUCTUOSO G, APARICIO J, LÓPEZ-SALA A ET AL. Resultados de la colocación del estimulador del nervio vago en epilepsia y calidad de vida en un hospital pediátrico. Neurología. 2015;30(8):465-471.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.